Libra Infusions (DHA:LIBRAINFU) Notes Receivable: BDT0.00 Mil (As of . 20)


DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT639.90
View Full Analysis

What is Libra Infusions Notes Receivable?

Libra Infusions DHA:LIBRAINFU -0.67% 20 Notes Receivable is BDT0.00 Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

Libra Infusions's Notes Receivable for the quarter that ended in . 20 was BDT0.00 Mil.

Libra Infusions Notes Receivable Related Terms

Libra Infusions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Notes Receivable Chart

Libra Infusions Annual Data
Trend
Notes Receivable

Libra Infusions Semi-Annual Data
Notes Receivable
DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of BDT0.00 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Notes Receivable of BDT0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' Notes Receivable too high?
Libra Infusions' current Notes Receivable is BDT0.00 Mil. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Notes Receivable compare to SECI and LENSF?
Libra Infusions' Notes Receivable of BDT0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Libra Infusions and its competitors. Libra Infusions's current Notes Receivable is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Notes Receivable of BDT0.00 Mil. The current Notes Receivable is BDT0.00 Mil. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Notes Receivable is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT639.90
Price